Close Menu

NEW YORK (360Dx) – Ortho Clinical Diagnostics and EKF Diagnostic today announced a deal to provide patients expanded access to EKF's beta-hydroxybutyrate assay for the diagnosis of ketoacidosis.

The assay is now available for use on Ortho's Vitros 4600 chemistry system and the Vitros 5600 integrated system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.